Genome Tuning Through HLA and KIR Gene Clusters Impact Susceptibility to Dengue

Overview

Journal Infect Med (Beijing)

Date 2023 Dec 11

PMID 38073888

Authors

Neha Sharma

Gaurav Sharma

Uma Kanga

Devinder Toor

Affiliations

Soon will be listed here.

Abstract

Dengue is amongst the most prevalent viral diseases which globally affects millions of individuals annually and renders billions at risk, particularly in tropical and sub-tropical nations. WHO estimated 100-400 million infections each year and reported 4.2 million active cases in 2019 worldwide. The infection is caused by arthropod-transmitted dengue virus which is known to have 5 serotypes (DENV1-5). Most of the cases show mild clinical symptoms; though others may develop severe forms viz; dengue hemorrhagic fever and dengue shock syndrome. Though limited literature suggests the population-specific genetic influence on susceptibility and the clinical course of dengue; the genetic propensity of dengue is largely unknown in most ethnicities. In this context, the human leukocyte antigen (HLA) system represents the most polymorphic region of the human genome and is crucial for the initiation of an appropriate immune response. In most of the genome-wide association studies, the HLA complex is the most significantly linked genetic region with susceptibility or protection towards various infectious and noninfectious diseases. Killer immunoglobulin-like receptors represent another highly variable system present on the surface of natural killer (NK) cells which regulate the activity of NK cells through interactions with their cognate HLA ligands. It is conceivable that the interaction of HLA-Killer immunoglobulin-like receptors systems influences the host susceptibility towards dengue infection as well the disease outcome. Here we attempt to review these parameters in dengue infection and disease outcome. Further detailed investigations are warranted towards the identification of novel susceptibility markers and targeted therapeutic interventions.

References

Dar L, Broor S, Sengupta S, Xess I, Seth P . The first major outbreak of dengue hemorrhagic fever in Delhi, India. Emerg Infect Dis. 1999; 5(4):589-90. PMC: 2627747. DOI: 10.3201/eid0504.990427. View

Malavige G, Rostron T, Rohanachandra L, Jayaratne S, Fernando N, De Silva A . HLA class I and class II associations in dengue viral infections in a Sri Lankan population. PLoS One. 2011; 6(6):e20581. PMC: 3111420. DOI: 10.1371/journal.pone.0020581. View

Simo F, Bigna J, Kenmoe S, Ndangang M, Temfack E, Moundipa P . Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies. Sci Rep. 2019; 9(1):13626. PMC: 6754462. DOI: 10.1038/s41598-019-50135-x. View

Castro M, Wilson M, Bloom D . Disease and economic burdens of dengue. Lancet Infect Dis. 2017; 17(3):e70-e78. DOI: 10.1016/S1473-3099(16)30545-X. View

Shepard D, Undurraga E, Halasa Y . Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis. 2013; 7(2):e2055. PMC: 3578748. DOI: 10.1371/journal.pntd.0002055. View

Vejbaesya S, Thongpradit R, Kalayanarooj S, Luangtrakool K, Luangtrakool P, Gibbons R . HLA Class I Supertype Associations With Clinical Outcome of Secondary Dengue Virus Infections in Ethnic Thais. J Infect Dis. 2015; 212(6):939-47. PMC: 4548457. DOI: 10.1093/infdis/jiv127. View

Kulkarni S, Martin M, Carrington M . The Yin and Yang of HLA and KIR in human disease. Semin Immunol. 2008; 20(6):343-52. PMC: 3501819. DOI: 10.1016/j.smim.2008.06.003. View

Visscher P, Brown M, McCarthy M, Yang J . Five years of GWAS discovery. Am J Hum Genet. 2012; 90(1):7-24. PMC: 3257326. DOI: 10.1016/j.ajhg.2011.11.029. View

McKechnie J, Beltran D, Pitti A, Saenz L, Arauz A, Vergara R . HLA Upregulation During Dengue Virus Infection Suppresses the Natural Killer Cell Response. Front Cell Infect Microbiol. 2019; 9:268. PMC: 6663972. DOI: 10.3389/fcimb.2019.00268. View

10.

Loke H, Bethell D, Phuong C, Dung M, Schneider J, White N . Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?. J Infect Dis. 2001; 184(11):1369-73. DOI: 10.1086/324320. View

11.

Durham N, Agrawal A, Waltari E, Croote D, Zanini F, Fouch M . Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics. Elife. 2019; 8. PMC: 6927745. DOI: 10.7554/eLife.52384. View

12.

Flipse J, Diosa-Toro M, Hoornweg T, van de Pol D, Urcuqui-Inchima S, Smit J . Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses. Sci Rep. 2016; 6:29201. PMC: 4933910. DOI: 10.1038/srep29201. View

13.

Eller M, Koehler R, Kijak G, Eller L, Guwatudde D, Marovich M . Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif. J Virol. 2011; 85(10):4802-11. PMC: 3126187. DOI: 10.1128/JVI.00111-11. View

14.

Alagarasu K, Mulay A, Singh R, Gavade V, Shah P, Cecilia D . Association of HLA-DRB1 and TNF genotypes with dengue hemorrhagic fever. Hum Immunol. 2013; 74(5):610-7. DOI: 10.1016/j.humimm.2013.01.027. View

15.

Wijayanti S, Porphyre T, Chase-Topping M, Rainey S, McFarlane M, Schnettler E . The Importance of Socio-Economic Versus Environmental Risk Factors for Reported Dengue Cases in Java, Indonesia. PLoS Negl Trop Dis. 2016; 10(9):e0004964. PMC: 5014450. DOI: 10.1371/journal.pntd.0004964. View

16.

Guzman M, Alvarez M, Halstead S . Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013; 158(7):1445-59. DOI: 10.1007/s00705-013-1645-3. View

17.

Hasan S, Jamdar S, Alalowi M, Al Beaiji S . Dengue virus: A global human threat: Review of literature. J Int Soc Prev Community Dent. 2016; 6(1):1-6. PMC: 4784057. DOI: 10.4103/2231-0762.175416. View

18.

Lan Nguyen T, Kikuchi M, Vu T, Do Q, Tran T, Vo D . Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis. 2008; 2(10):e304. PMC: 2553281. DOI: 10.1371/journal.pntd.0000304. View

19.

Duan Z, Liu H, Huang X, Wang S, Yang J, Chen X . Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2. Virus Res. 2014; 196:5-12. DOI: 10.1016/j.virusres.2014.10.022. View

20.

Guzman M, Halstead S, Artsob H, Buchy P, Farrar J, Gubler D . Dengue: a continuing global threat. Nat Rev Microbiol. 2010; 8(12 Suppl):S7-16. PMC: 4333201. DOI: 10.1038/nrmicro2460. View